Cargando…
A tumor cord model for Doxorubicin delivery and dose optimization in solid tumors
BACKGROUND: Doxorubicin is a common anticancer agent used in the treatment of a number of neoplasms, with the lifetime dose limited due to the potential for cardiotoxocity. This has motivated efforts to develop optimal dosage regimes that maximize anti-tumor activity while minimizing cardiac toxicit...
Autor principal: | Eikenberry, Steffen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736154/ https://www.ncbi.nlm.nih.gov/pubmed/19664243 http://dx.doi.org/10.1186/1742-4682-6-16 |
Ejemplares similares
-
Tumor-Immune Interaction, Surgical Treatment, and Cancer Recurrence in a Mathematical Model of Melanoma
por: Eikenberry, Steffen, et al.
Publicado: (2009) -
Co-Encapsulation of Doxorubicin With Galactoxyloglucan Nanoparticles for Intracellular Tumor-Targeted Delivery in Murine Ascites and Solid Tumors
por: Joseph, Manu M., et al.
Publicado: (2014) -
Targeted delivery of doxorubicin to HER2 positive tumor models
por: Gomari, Hosna, et al.
Publicado: (2019) -
Tumor targeted delivery of doxorubicin in malignant peripheral nerve sheath tumors
por: Madhankumar, A. B., et al.
Publicado: (2018) -
A Mathematical Model for Thermosensitive Liposomal Delivery of Doxorubicin to Solid Tumour
por: Zhan, Wenbo, et al.
Publicado: (2013)